Advil® / Motrin®
Ibuprofen
Version 2025-04 · Last reviewed April 1, 2025 · Methodology
List Price
$3–15
With Insurance
$3–10 (OTC)
How It Works
Ibuprofen blocks both COX-1 and COX-2 — the enzymes that produce prostaglandins. Prostaglandins are local signaling molecules that sensitize pain receptors, raise body temperature, and amplify inflammation. By blocking their production, ibuprofen reduces pain, fever, and swelling simultaneously.
Why the side effects happen
The GI toxicity (ulcers, bleeding) comes directly from COX-1 inhibition in the stomach lining — the same enzyme ibuprofen blocks for pain also protects the stomach. This is why taking ibuprofen with food helps (mechanical protection). Kidney effects occur because prostaglandins maintain kidney blood flow — in dehydrated or elderly patients, blocking COX disrupts this protection, causing acute kidney injury. Cardiovascular risk is from COX-2 inhibition in blood vessels.
When Will I Feel It?
Pain relief begins within 30–60 minutes. Anti-inflammatory effect requires consistent dosing over 24–48 hours to build up.
Analgesic effect begins — pain signals are dampened as prostaglandin synthesis falls.
Peak pain relief and fever reduction. Anti-inflammatory effect is building.
Full anti-inflammatory effect — tissue prostaglandins are chronically suppressed with regular dosing. Taking it only occasionally gives mainly analgesia, not full anti-inflammation.
Adherence Note
For acute pain: single doses work. For inflammatory conditions (bursitis, tendinitis, arthritis flares): regular dosing every 6–8 hours with food for 7–14 days builds the anti-inflammatory effect. Never exceed 2400mg/day without medical supervision.
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Common Side Effects
While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.
GI upset / nausea / heartburn
15–20%Always take with food; consider a PPI if using daily for >2 weeks (though PPIs carry their own long-term risks)
Headache / dizziness
5–10%Usually mild; ensure adequate hydration
Elevated blood pressure
5%NSAIDs cause sodium and water retention; monitor BP if on blood pressure medications
Disrupted ovulation (LUF syndrome)
75% in mid-cycle useCRITICAL for women trying to conceive: avoid NSAIDs entirely around ovulation (days 10–18 of cycle). Use acetaminophen instead.
Compensated hypogonadism (men, chronic use)
Documented at 6 weeksElevated LH with suppressed testosterone reported in young men after 6 weeks of regular use; discuss with doctor if using long-term
Edema / fluid retention
5%Most common in elderly; report ankle swelling or weight gain
Serious Adverse Effects
- • Peptic ulcer and GI bleeding — 15–20% of long-term users develop ulcers; risk is highest in elderly, with alcohol, or with anticoagulants
- • Cardiovascular events (MI, stroke) — class-wide FDA black box; risk increases with higher doses and longer duration; avoid in heart disease patients
- • Acute kidney injury — especially in dehydrated patients, elderly, or those on ACE inhibitors/diuretics
- • Reproductive toxicity — luteinized unruptured follicle syndrome in women (75% failed ovulation); compensated hypogonadism in men (PNAS 2018)
- • Reye's syndrome — ibuprofen in children with viral infections; acetaminophen preferred in children
- • Severe skin reactions (SJS/TEN) — rare but life-threatening hypersensitivity
Drug Interactions
Major Interactions (Avoid)
Moderate Interactions (Caution)
Food Interactions
When to Contact Your Doctor
This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician — do not wait for your next scheduled appointment.
Contact soon if you notice
- Peptic ulcer and GI bleeding — 15–20% of long-term users develop ulcers; risk is highest in elderly, with alcohol, or with anticoagulants
- Cardiovascular events (MI, stroke) — class-wide FDA black box; risk increases with higher doses and longer duration; avoid in heart disease patients
- Acute kidney injury — especially in dehydrated patients, elderly, or those on ACE inhibitors/diuretics
- Reproductive toxicity — luteinized unruptured follicle syndrome in women (75% failed ovulation); compensated hypogonadism in men (PNAS 2018)
- Black, tarry, or bloody stools — stop immediately and seek emergency care (GI bleeding)
Also discuss if you want to
- Review whether this medication is still appropriate for you
- Consider dosage adjustments based on response
- Explore lifestyle or non-drug alternatives
- Understand stopping or tapering options
- Plan monitoring labs and follow-up
In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.
Special Populations
Safety classifications for specific groups — discuss with your provider before use.
After 20 weeks: associated with fetal kidney problems and oligohydramnios (low amniotic fluid). FDA warning 2020. First trimester: possible miscarriage risk. Acetaminophen is the recommended alternative.
Low levels in breast milk; considered compatible with nursing for short-term use. Occasional use is generally acceptable.
Estrogen was protective against cardiovascular disease. After menopause, that protection is gone — and regular NSAID use adds additional cardiovascular and kidney stress on top of that increased baseline risk. The risk calculation for routine ibuprofen use changes significantly after menopause. Discuss safer alternatives for chronic pain with your doctor.
Approved for children 6 months+. Must be weight-dosed. Never give aspirin to children with viral illness (Reye's). Do not use ibuprofen in dehydrated or vomiting children — kidney injury risk.
Beers Criteria: NSAIDs are high-risk in elderly. Dramatically increased GI bleeding, cardiovascular, and kidney injury risk. Avoid unless no alternative; if used, lowest dose for shortest time with a PPI.
NSAIDs reduce renal prostaglandin synthesis — required for kidney perfusion. Can precipitate acute kidney injury. Avoid in eGFR <60.
Avoid in severe hepatic impairment; monitor liver function with regular use.
FDA Adverse Event Reports
Patient-filed reports from the FDA FAERS database · refreshed daily
Community Reports
User-reported experiences — anonymous & anecdotal
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Metabolic & Lifestyle Alternatives
Pain & Inflammation Without Disrupting Hormones or the Stomach Lining
Curcumin matched ibuprofen for knee osteoarthritis pain in a published RCT — without GI damage or reproductive effects
Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.
Curcumin (BCM-95 or C3 complex, 500mg twice daily)
Highly bioavailable form
RCT: equal efficacy to ibuprofen 800mg for knee OA pain at 6 weeks; no GI effects
Omega-3 (EPA 2g/day)
Fish oil or algae oil
Anti-inflammatory via COX pathway — multiple RCTs show reduced NSAID requirements in RA and general pain
Cold therapy (ice, 20 min on/20 min off)
Immediate application to acute injury
Reduces prostaglandin-driven inflammation at injury site without systemic COX inhibition; safe in pregnancy and fertility
Boswellia serrata (AKBA form, 100–250mg/day)
Frankincense extract
Inhibits 5-LOX pathway (different from COX); RCT: significant osteoarthritis pain reduction at 8 weeks
Acetaminophen (for fever/pain without inflammation)
325–650mg as needed
Safe alternative for pain and fever; does not inhibit COX-1 (no GI, cardiovascular, or reproductive risks at standard doses)
Extra virgin olive oil (oleocanthal, 50ml/day)
High-polyphenol EVOO — early harvest, >250mg/kg oleocanthal; look for strong throat "sting"
Oleocanthal inhibits both COX-1 and COX-2 enzymes on a molar basis comparably to ibuprofen — without GI toxicity, renal harm, or reproductive effects. In vitro studies show greater COX inhibitory potency per gram than ibuprofen.
Key Studies
Global Prescribing & Pricing
The US allows OTC ibuprofen doses up to 400mg; most countries limit OTC access to 200mg with stricter duration guidance
United States
$3–10/mo
400mg OTC available; most consumed OTC analgesic globally; no systematic duration warnings on packaging
No mandated pharmacist consultation; 400mg OTC without guidance; duration warnings minimal on labeling
OTC — no prescription needed
United Kingdom
~$2–6/mo
400mg OTC available but MHRA guidance: 200mg for initial OTC dosing; max 3–5 days for pain without medical advice
MHRA requires pharmacist access in many settings; packaging includes explicit duration and GI risk warnings; NHS discourages long-term OTC use
OTC with pharmacist guidance
Germany
~$4–10/mo
400mg Rx required; 200mg OTC available; strict pharmacist counseling required
Prescription required for 400mg+ doses; pharmacist required to counsel on GI and cardiovascular risks at point of sale
GKV covered when prescribed; OTC 200mg available
France
~$3–8/mo
Strict OTC restrictions; strong pharmacist gatekeeping
ANSF (French FDA equivalent) restricted some high-dose OTC ibuprofen in 2019 following GI safety concerns; advertising restrictions on OTC analgesics
Covered by Assurance Maladie when prescribed
Japan
~$5–12/mo
Lower overall NSAID use; acetaminophen culturally preferred
OTC ibuprofen available only in lower doses; pharmacist counseling mandatory; Japanese prescribing culture generally favors lower doses and shorter courses
Covered by JHIS when prescribed
The 2015 Human Reproduction study showing 75% failed ovulation in women taking NSAIDs mid-cycle was published in a major peer-reviewed journal. Germany's pharmacist prescription requirement for 400mg doses means patients receive counseling about these risks before purchase. The US has no equivalent gatekeeping for a drug that disrupts ovulation in three-quarters of women who take it at the wrong time in their cycle.
Clinical Trials & Funding
Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid — they undergo the same FDA review — but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.
Funding Sources
The PRECISION trial (2016) comparing ibuprofen, naproxen, and celecoxib for cardiovascular safety was funded by Pfizer — which manufactures Celebrex (celecoxib). The trial was designed after the rofecoxib (Vioxx) cardiovascular disaster. Independent researchers noted the trial enrolled patients already taking PPIs and low-dose aspirin — populations that reduce GI risk and confound true real-world NSAID safety data. The OTC approval of 400mg doses (higher than most countries allow OTC) was granted in the US without the systematic long-term reproductive safety studies that have since emerged.
Declared Conflicts of Interest
Merck's rofecoxib (Vioxx) was withdrawn in 2004 after VIGOR showed 5× increased MI risk — Merck had suppressed cardiovascular data. This shaped all subsequent NSAID safety research. The 2018 Kristensen PNAS study on male hypogonadism and the 2015 Duvan fertility study were published decades after ibuprofen became the world's most consumed OTC drug — the reproductive safety window was never systematically studied during approval.
Key Efficacy Results
Effective analgesic and anti-inflammatory; however, 75% failed ovulation in women taking NSAIDs mid-cycle; compensated hypogonadism in young men after 6 weeks; 15–20% peptic ulcer incidence in chronic users
Referenced Studies
Each study carries a Cochrane RoB-2 risk-of-bias badge — tap the badge for details.
Evidence & Transparency
Cochrane RoB-2 (Risk of Bias)
Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗
CMS Open Payments
Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears" — never definitive clinical claims. CMS Open Payments ↗
Live Clinical Trials
Live from ClinicalTrials.gov · refreshed every 4 hours
Currently enrolling, active, and recently completed studies involving Ibuprofen. Data is pulled directly from the U.S. National Library of Medicine.
Recent Research
Live from PubMed · peer-reviewed literature · refreshed every 4 hours
Most recently indexed clinical trials and systematic reviews mentioning Ibuprofen in PubMed.
Source Documentation
Structured citations for referenced clinical trials
Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.
| Trial | Registry ID | Cite |
|---|---|---|
| NSAIDs & Female Ovulation (Human Reproduction 2015) | PMID:25740884 | |
| Ibuprofen & Male Compensated Hypogonadism (PNAS 2018) | PMID:29531107 | |
| PRECISION Trial (NEJM 2016) | PMID:27356222 |
Bias ratings use Cochrane RoB-2 methodology. Editorial assessment — not a certified Cochrane review.
Our MethodologyMedical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Stopping This Medication Safely
NSAIDs do not cause physical dependence and can be stopped at any time without withdrawal. However, underlying pain will return — this is expected. If the pain is chronic, the root cause requires investigation rather than indefinite NSAID use.
What Published Research Shows About Stopping This Medication
This summarizes what published research documents — it is not personal medical advice. Any changes to your medication require discussion with your prescribing physician.
- ·Research shows no pharmacological taper is needed for ibuprofen
- ·For chronic pain management, research supports identifying and treating the underlying cause rather than indefinite NSAID use
- ·Research documents medication overuse headache when ibuprofen is used >15 days/month for headaches — a cycle documented in clinical literature
- ·Research supports alternative pain management approaches (physical therapy, curcumin, omega-3) before stopping if pain is ongoing
Warning Symptoms — Contact Your Doctor If You Experience:
- Black, tarry, or bloody stools — stop immediately and seek emergency care (GI bleeding)
- Dark urine with decreased urination — possible kidney injury
- Severe stomach or abdominal pain
- Chest pain or shortness of breath after starting NSAIDs
Never change or stop a medication without consulting your prescribing physician.
Questions for Your Doctor
Questions to Ask
- 1.I am trying to conceive — should I avoid ibuprofen around the time of ovulation, and what is the safest alternative for pain?
- 2.I'm a man using ibuprofen regularly — should I have my testosterone levels checked?
- 3.I have GERD or stomach issues — is it safe for me to take NSAIDs regularly, and should I be on a stomach protectant?
- 4.I take lisinopril or another blood pressure medication — is ibuprofen safe to combine?
- 5.What is the minimum effective dose and duration for my condition?
Lab Tests to Request
- Kidney function (eGFR) before and during chronic use
- Complete blood count — monitor for GI bleeding (iron-deficiency anemia)
- Blood pressure — NSAIDs can elevate BP
- Testosterone + LH (for men on chronic NSAID therapy)
- Stool occult blood test (chronic users)
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Frequently Asked Questions About Advil® / Motrin®
- What is Advil® / Motrin® used for?
- Advil® / Motrin® (Ibuprofen) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) manufactured by Pfizer (Advil) / J&J (Motrin) / Generic. FDA-approved indications include: Mild-to-moderate pain; Fever reduction; Inflammation (arthritis, tendinitis); Dysmenorrhea (menstrual cramps); Headache; Minor musculoskeletal injuries.
- What are the common side effects of Advil® / Motrin®?
- Common side effects of Advil® / Motrin® include: GI upset / nausea / heartburn (15–20%); Headache / dizziness (5–10%); Elevated blood pressure (5%); Disrupted ovulation (LUF syndrome) (75% in mid-cycle use); Compensated hypogonadism (men, chronic use) (Documented at 6 weeks).
- How much does Advil® / Motrin® cost?
- Advil® / Motrin® list price is approximately $3–15. With insurance it typically costs $3–10 (OTC); without insurance approximately $3–10 (OTC).
- Who funded the clinical trials for Advil® / Motrin®?
- The PRECISION trial (2016) comparing ibuprofen, naproxen, and celecoxib for cardiovascular safety was funded by Pfizer — which manufactures Celebrex (celecoxib). The trial was designed after the rofecoxib (Vioxx) cardiovascular disaster. Independent researchers noted the trial enrolled patients already taking PPIs and low-dose aspirin — populations that reduce GI risk and confound true real-world NSAID safety data. The OTC approval of 400mg doses (higher than most countries allow OTC) was granted in the US without the systematic long-term reproductive safety studies that have since emerged.
- How strong is the clinical evidence for Advil® / Motrin®?
- Key studies: VIGOR trial context (naproxen comparison), multiple OA/pain trials, PRECISION trial (cardiovascular safety). Effective analgesic and anti-inflammatory; however, 75% failed ovulation in women taking NSAIDs mid-cycle; compensated hypogonadism in young men after 6 weeks; 15–20% peptic ulcer incidence in chronic users Potential conflicts of interest: Merck's rofecoxib (Vioxx) was withdrawn in 2004 after VIGOR showed 5× increased MI risk — Merck had suppressed cardiovascular data. This shaped all subsequent NSAID safety research. The 2018 Kristense.
- Are there non-drug alternatives to Advil® / Motrin®?
- Curcumin matched ibuprofen for knee osteoarthritis pain in a published RCT — without GI damage or reproductive effects See the Alternatives tab for full details.
Get notified when we update Advil® / Motrin®
We'll email you when new evidence, safety updates, or alternatives are added.
No spam. Unsubscribe anytime.